Abeona Therapeutics Inc.

NASDAQ: ABEO
Share price (11/20/24): $5.75
Market cap (11/20/24): $250 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration – amended

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Janus Henderson Group plc

Point72 Asset Management, L.P.

Seshadri Vishwas

Integrated Core Strategies (US) LLC

Seshadri Vishwas

News Filter

Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-Cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

Therapeutics® Completes Pz-Cel Biologics License Application Resubmission to U.S. Food and Drug Administration

Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to Its Board of Directors

Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type a Meeting With FDA to Align on Upcoming Pz-Cel BLA Resubmission

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Notice of effectiveness